Baclofen for Muscle Relaxation: Dosing and Management
Baclofen should be initiated at 5 mg three times daily and titrated gradually every 3 days (5 mg TID → 10 mg TID → 15 mg TID → 20 mg TID) to an optimal dose typically between 40-80 mg daily, with a maximum of 80 mg daily (20 mg four times daily). 1
Indications and Approved Uses
Baclofen is FDA-approved specifically for spasticity from multiple sclerosis and spinal cord injuries/diseases, not for skeletal muscle spasm from rheumatic disorders 1. The drug has not established efficacy in stroke, cerebral palsy, or Parkinson's disease and is not recommended for these conditions 1.
Titration Protocol
The FDA-approved titration schedule follows a structured 12-day escalation 1:
- Days 1-3: 5 mg three times daily
- Days 4-6: 10 mg three times daily
- Days 7-9: 15 mg three times daily
- Days 10-12: 20 mg three times daily
- Beyond Day 12: Further increases may be necessary, but total daily dose should not exceed 80 mg daily 1
The lowest dose compatible with optimal response is recommended 1. In older adults, doses rarely exceed 30-40 mg per day due to tolerability issues including muscle weakness, urinary dysfunction, cognitive effects, and sedation 2.
Critical Safety Considerations
Withdrawal Risk (Life-Threatening)
Never abruptly discontinue baclofen—this is potentially fatal 2. Withdrawal symptoms include 2:
- Visual and auditory hallucinations
- Anxiety, agitation, delirium
- Fever, tremors, tachycardia
- Seizures
- Intrathecal baclofen withdrawal: High fever, altered mental status, rebound spasticity, muscle rigidity leading to rhabdomyolysis, multiorgan failure, and death 2
If discontinuation is necessary, taper slowly over 1-2 weeks 2. For patients on long-term therapy, perioperative management requires specialist input, particularly for intrathecal baclofen 2.
Perioperative Management
Continue baclofen preoperatively including the day of operation 2. This recommendation prioritizes avoiding potentially life-threatening withdrawal over concerns about increased sedation with anesthetics 2.
Adverse Effects Profile
Common adverse effects include 2, 3, 4:
- Sedation and drowsiness (dose-dependent)
- Muscle weakness (monitor carefully)
- Fatigue and somnolence 4
- Dizziness 4
- Dry mouth 4
- Paraesthesia 4
- Muscle spasms/rigidity 4
- Urinary dysfunction 2
- Cognitive effects 2
Adverse effects occur in 25-75% of patients taking oral baclofen, often limiting its usefulness 3.
Efficacy Evidence
Moderate to high-certainty evidence demonstrates that baclofen 4:
- Reduces relapse risk (RR 0.87,95% CI 0.77-0.99) particularly in detoxified patients
- Increases percentage of days abstinent (MD 9.07%, 95% CI 3.30-14.85)
- Does not reduce heavy drinking days or drinks per drinking day
- Does not increase dropout rates or adverse event-related dropouts
For spasticity, baclofen effectively relieves flexor spasms, pain, clonus, and muscular rigidity in multiple sclerosis patients 5.
Special Populations and Contraindications
Renal/Hepatic Impairment
Do not modify the initial dose in renal or hepatic failure 2. However, baclofen accumulates with prolonged use in renal insufficiency, potentially requiring dose adjustments over time 6. Monitor for rising blood levels in patients with neurogenic bladder and potential renal insufficiency 6.
Drug Interactions
Baclofen potentiates sedation when combined with 2:
- Opioids
- Other CNS depressants
- Anesthetic agents
Alternative Considerations
If baclofen fails due to intolerable side effects or inadequate response at maximum dose, consider 3:
- Intrathecal baclofen: Bypasses blood-brain barrier, optimizes efficacy while minimizing systemic side effects 3, 7
- Tizanidine: α2-adrenergic agonist with similar mechanism but different side effect profile 2
- Botulinum toxin: For localized spasticity in upper or lower limbs 2
Avoid benzodiazepines (including diazepam) during stroke recovery due to deleterious effects on neurological recovery, despite their antispastic properties 2.
Monitoring Requirements
- Assess muscle strength, urinary function, and cognitive status regularly 2
- Monitor for sedation, particularly when initiating therapy or increasing doses 2
- In patients with renal impairment, consider monitoring baclofen blood levels if available 6
- Evaluate efficacy after reasonable trial period; if no benefit, slowly withdraw 1